Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Matheus Tannus"'
Autor:
Matheus Tannus, Davi Tanajura, Michael A. Sundberg, Paulo Oliveira, Neviton Castro, André Muniz Santos
Publikováno v:
Case Reports in Medicine, Vol 2011 (2011)
The HTLV-1 virus is a known agent involved in the development of HAM/TSP. Past studies have typically observed patients with autonomic dysfunction consisting of detrusor overactivity and detrusor-sphincter dyssynergia, with the occasional observation
Externí odkaz:
https://doaj.org/article/0d9049f795584023b5f30299b3ab0cbc
Autor:
Cassius J V de Oliveira, José Abraão Carneiro Neto, Sheila N F Liberato de Matos, Paulo Oliveira, Matheus Tannus, Néviton Castro, Paulo N Rocha, Edgar M Carvalho
Publikováno v:
The Journal of Sexual Medicine. 20:269-276
BackgroundVirtually all patients with human T-lymphotropic virus 1 (HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) have some degree of erectile dysfunction (ED), but ED is also found in a large percentage of HTLV-1 carriers.Ai
Publikováno v:
Journal of Endourology. 28:487-492
Surgery continues to be the main form of treatment for patients with renal tumors. We create a more practical and intuitive score for renal tumor classification.Eighty patients underwent surgery for renal tumors and were prospectively enrolled. The t
Autor:
Paulo J. Oliveira, Weslley Santiago Andrade, Carlos Roberto A. Oliveira, José Luciano R. Araújo, Humberto Laydner, Tafadzwa P. Makarawo, Matheus Tannus
Publikováno v:
BJU International. 107:1104-1109
Study Type – Therapy (systematic review) Level of Evidence 1a What’s known on the subject? and What does the study add? Phosphodiesterase 5 inhibitors improve lower urinary tract symptoms (LUTS), however the maximum urinary flow rate is not signi
Publikováno v:
ISRN Endoscopy.
Objectives. To evaluate the trends of surgical treatment of the renal tumor in an academic medical center. Methods. Between 2001 and 2010, 505 were treated surgically at the Federal University of Sao Paulo for renal tumors. The following variables we
Autor:
Néviton Castro, Natália Carvalho, Silvane Santos, Paulo J. Oliveira, Rosana Andrade, Matheus Tannus, Davi Costa, Edgar M. Carvalho
Publikováno v:
Urology. 81(6)
To evaluate the immune response and proviral load in individuals with human T-lymphotropic virus type 1 (HTLV-1) and erectile dysfunction (ED) compared with those in the controls.We performed a cross-sectional study of 102 men aged 18-70 years with p
Autor:
Isadora Cristina de Siqueira, Davi Tanajura, Silvane B. Santos, Thais Delavechia, Glória Orge, Edgar M. Carvalho, Marshall J. Glesby, Anselmo Souza, Matheus Tannus, Paulo J. Oliveira, André Luiz Muniz, Tania Luna, Márcia Nascimento
Publikováno v:
Retrovirology
Results We demonstrated that cells from HTLV-1 overactive bladder produce higher spontaneous levels of IFN-g, TNF-a and IL-17 than carriers and similar levels of TNF-a and IL-17 to HAM/TSP. Proviral load was higher in HTLV-1 overactive bladder and HA
Autor:
Tânia Luna, Michael Sundberg, Katia Viana, Matheus Tannus, Davi Costa, Valéria Gusmão, Edgar M. Carvalho, Taís Dellavechia, André Muniz dos Santos, Lorena Dantas, Anselmo Souza, Glória Orge, Néviton Castro, Silvany Braga
Publikováno v:
Retrovirology, Vol 8, Iss Suppl 1, p A62 (2011)
Retrovirology
Retrovirology
Background It’s estimated that 10 to 20 million people are infected with the HTLV-1 virus worldwide. Two principal diseases are associated with this virus: the Adult T-cell Lymphoma/Leukemia (ATLL), and the HTLV-1 Associated Myelopathy/ Tropical Sp
Autor:
Paulo J. Oliveira, Matheus Tannus, Michael A Sundberg, André Luiz Muniz Alves dos Santos, Néviton Castro, Davi Tanajura
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2011 (2011)
Case Reports in Medicine, Vol 2011 (2011)
The HTLV-1 virus is a known agent involved in the development of HAM/TSP. Past studies have typically observed patients with autonomic dysfunction consisting of detrusor overactivity and detrusor-sphincter dyssynergia, with the occasional observation
Autor:
Humberto K, Laydner, Paulo, Oliveira, Carlos Roberto A, Oliveira, Tafadzwa P, Makarawo, Weslley S, Andrade, Matheus, Tannus, José Luciano R, Araújo
Publikováno v:
BJU international. 107(7)
• To review the evidence in support of the effectiveness of phosphodiesterase 5 inhibitors in lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).• Relevant studies were identified by performing a literature search us